Kidney Cancer: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for kidney cancer. To learn more about a study, choose from the list below.

Showing 19 trials
Title Investigator
A Phase I Study of AGS-16C3F in Patients with Clear Cell or Papillary Renal Cell Cancer
[Protocol 12-162]
Molina, Ana Maria, MD
A Phase I Study of Axitinib plus Dalantercept for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin, MD
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer
[Protocol 13-118]
Voss, Martin, MD
A Phase I Study of Lirilumab plus Nivolumab in Patients with Advanced Solid Tumors
[Protocol 12-224]
Segal, Neil, MD, PhD
A Phase I Study of Nivolumab in Combination with Sunitinib or Pazopanib in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147]
Voss, Martin, MD
A Phase IB Study of SGN-75 plus Everolimus in Patients with CD70-Positive Metastatic Renal Cell Cancer
[Protocol 12-263]
Molina, Ana Maria, MD
A Phase IB/II study of E7080 plus Everolimus in Patients with Unresectable Advanced/Metastatic Renal Cell Carcinoma
[Protocol 10-084]
Molina, Ana Maria, MD
A Phase II Study of Everolimus as Second-Line Therapy in the Treatment of Metastatic Renal Cell Carcinoma
[Protocol 11-197]
Motzer, Robert, MD
A Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208]
Coleman, Jonathan, MD
A Phase II Study of Gemcitabine and Pazopanib in Previously Untreated Patients with Advanced Urothelial Cancers Who Cannot Receive Cisplatin
[Protocol 11-191]
Bajorin, Dean, MD
A Phase II Study of New Treatment Approaches for High-Risk Renal Tumors
[Protocol 12-026]
Kobos, Rachel, MD
A Phase II Study of SNX-5422 in Patients with Select Advanced HER2 Cancers
[Protocol 13-112]
Voss, Martin, MD
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Molina, Ana Maria, MD
A Phase III Study of BMS-936558 Versus Everolimus in Patients with Advanced or Metastatic Renal Cell Carcinoma Who Received Prior Anti-Angiogenic Therapy
[Protocol 12-159]
Motzer, Robert, MD
A Phase III Study of Cabozantinib versus Everolimus in Patients with Progressive Kidney Cancer
[Protocol 13-124]
Motzer, Robert, MD
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119]
Rosenberg, Jonathan, MD
A Phase III Study of Pazopanib as Adjuvant Therapy for Patients with Localized or Locally Advanced Renal Cell Carcinoma Following Nephrectomy
[Protocol 10-162]
Motzer, Robert, MD
Renal Tumor Classification, Biology, and Banking Study
[Protocol 12-014]
Kobos, Rachel, MD
Treatment for Very Low-Risk and Standard-Risk Favorable Histology Wilms Tumor
[Protocol 12-084]
Kobos, Rachel, MD